BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Art Pappas will be on a panel at the UNC Alternative Investments Conference in Chapel Hill, NC.
News | 02. 16. 2011
